Patoloxía Molecular das Doenzas Raras
PatMol-DR
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (47)
2024
-
Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)
European Journal of Heart Failure
2023
-
Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study
European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360
-
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants
Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 8
2022
-
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine, Vol. 20, Núm. 1
-
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 5, pp. 721-728
-
Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response
Revista Espanola de Cardiologia
-
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
European Journal of Clinical Investigation, Vol. 52, Núm. 7
-
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
Celia’s encephalopathy (Bscl2-gene-related): Current understanding
Journal of Clinical Medicine, Vol. 10, Núm. 7
-
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
BMC Medicine, Vol. 19, Núm. 1
2020
-
Evidence of ongoing complement activation on adipose tissue from an 11-year-old girl with Barraquer–Simons syndrome
Journal of Dermatology, Vol. 47, Núm. 12, pp. 1439-1444
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
2019
-
Celia’s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant
Neurogenetics, Vol. 20, Núm. 2, pp. 73-82
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
2018
-
Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy
European Journal of Human Genetics, Vol. 26, Núm. 3, pp. 396-406
2017
-
La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca
Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 338-346
-
Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure
International Journal of Cardiology, Vol. 240, pp. 265-270
2016
-
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553
-
Skipped BSCL2 transcript in celia's encephalopathy (PELD): New insights on fatty acids involvement, senescence and adipogenesis
PLoS ONE, Vol. 11, Núm. 7